KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Leases (2020 - 2025)

Historic Current Leases for Adaptive Biotechnologies (ADPT) over the last 6 years, with Q3 2025 value amounting to $9.4 million.

  • Adaptive Biotechnologies' Current Leases fell 577.79% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 577.79%. This contributed to the annual value of $10.2 million for FY2024, which is 911.13% up from last year.
  • Adaptive Biotechnologies' Current Leases amounted to $9.4 million in Q3 2025, which was down 577.79% from $10.0 million recorded in Q2 2025.
  • Adaptive Biotechnologies' Current Leases' 5-year high stood at $10.5 million during Q1 2025, with a 5-year trough of $4.3 million in Q1 2021.
  • Moreover, its 5-year median value for Current Leases was $9.3 million (2023), whereas its average is $8.5 million.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 18681.76% in 2021, then plummeted by 577.79% in 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Current Leases (Quarter) stood at $5.1 million in 2021, then soared by 82.59% to $9.2 million in 2022, then grew by 1.67% to $9.4 million in 2023, then rose by 9.11% to $10.2 million in 2024, then decreased by 7.78% to $9.4 million in 2025.
  • Its Current Leases stands at $9.4 million for Q3 2025, versus $10.0 million for Q2 2025 and $10.5 million for Q1 2025.